Case Studies

Challenge A major pharmaceutical company asked us for support in the medical safety and pharmacovigilance due diligence and assessment of a Phase III in-licensing opportunity. The drug in question...

Challenge A venture capital investor needed an assessment of the technical, regulatory and market risks in a neuroscience specialty pharma company developing a range of products through the 505...

Challenge A European pharma company seeking to license a development-stage follow-on biologic needed to assess the commercial potential of a second-generation antibody against a validated oncology...

Challenge An established US biotech company was looking for a team of expert antibody consultants to help them understand the potential of monoclonal antibodies (mAbs) to treat bacterial infections.

Challenge: We were asked to conduct an assessment of an AAV gene therapy for an ophthalmic indication, focusing on market potential, technical and regulatory issues and the identification of key...

Challenge A pharma company needed help conducting due diligence on an in-licensing/acquisition candidate for a Phase IIb respiratory drug.

Challenge A life science venture capital fund was contemplating investing in advanced plasma product opportunities being developed by a biopharmaceutical company, and needed a reality check on the...

Challenge A venture-backed biotech company developing a clinical stage asset for the treatment of early-stage cancer was populating a data room and preparing for negotiations with a major pharma...

Challenge A major European venture capital investor needed to analyze the business plan of a novel point-of-care diagnostics company.

Challenge After a seed investment, Evgen, a start-up biotech had built an IP portfolio in the field of glucosinolates, chemicals found in brassica vegetables, that are potent inducers of...

Challenge Our client, a commercial stage biotech company focused on rare and ultra-rare diseases was seeking to build its pipeline of development products. Whilst it had an established business...

Challenge A listed North American firm needed support with the identification of early-stage in-licensing or acquisition opportunities in the highly competitive field of regenerative medicine....